Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study - Poll - MDSpire

Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study

  • By

  • Isabel Leroux-Roels

  • Azhar Alhatemi

  • Magalie Caubet

  • Fien De Boever

  • Bertrand de Wergifosse

  • Mohamed El Idrissi

  • Guilherme S Ferreira

  • Bart Jacobs

  • Axel Lambert

  • Sandra Morel

  • Charlotte Servais

  • Juan Pablo Yarzabal

  • October 24, 2024

  • 0 min

Share

Original Source(s)

Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study

  • by Isabel Leroux-Roels, Azhar Alhatemi, Magalie Caubet, Fien De Boever, Bertrand de Wergifosse, Mohamed El Idrissi, Guilherme S Ferreira, Bart Jacobs, Axel Lambert, Sandra Morel, Charlotte Servais, Juan Pablo Yarzabal

  • October 24, 2024

Related Content

Microbiome analysis and fecal microbiota transfer in pediatric gastroenterology — a structured online survey in German-speaking countries

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Clostridium difficile infection after stoma reversal surgery: a systematic review and meta-analysis of the literature